Adcetris 50mg injection is an anticancer medication that belongs to the CD30 monoclonal antibodies category containing the active ingredient Brentuximab vedotin. This medication is used to treat certain types of cancer, including classical Hodgkin lymphoma (cancer of the lymphatic system), cutaneous T-cell lymphoma (a type of non-Hodgkin lymphoma that affects the skin), and systemic anaplastic large-cell lymphoma (abnormal growth of T-lymphocytes). This drug is an antibody-drug conjugate (ADC) that targets cancer cells specifically. It may be used as a frontline treatment or when other treatments are ineffective.

Adcetris 50mg injection is contraindicated in individuals with known hypersensitivity or allergy to it or its component. Inform your physician if you have any pre-existing medical conditions of liver, kidney, or heart disease. Your doctor will perform regular blood tests to ensure the safety of receiving this medicine and to monitor for any serious adverse effects. Infusion site reactions can happen during treatment, including wheezing, difficulty breathing, hives, itching, or swelling. These symptoms require immediate medical attention.

If you and your partner are undergoing treatment with this drug, it is advised to use two effective methods of contraception during the treatment period. This is to prevent pregnancy while taking the medication. Women are advised to continue using contraception for an additional 6 months after the last dose of this injection. This extended period helps ensure that the medication is completely cleared from the body before attempting to conceive. Adcetris 50mg injection can cause fetal harm to the fetus when administered to pregnant women. Consult your doctor if you are pregnant, breastfeeding, or planning for pregnancy during the treatment.

Very secure payment methods
Shipping will be calculated on checkout
Please note that price may increase due to exchange rate, ensure updated price before making payment